Mangoceuticals (MGRX) Short-term Investments (2023 - 2026)

Mangoceuticals has disclosed Short-term Investments across 4 years of filings, most recently posting $16957.0 for Q2 2026.

• In Q2 2026, Short-term Investments changed 0.09% year-over-year to $16957.0; the TTM figure through Jun 2026 stood at $16957.0 (changed 0.09% YoY), while the FY2025 annual figure was $33899.0, up 100.09% from the prior year.
• Short-term Investments came in at $16957.0 for Q2 2026 at Mangoceuticals, roughly flat from $16957.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $33899.0 in Q4 2025 to a low of $16942.0 in Q4 2023.
• Average Short-term Investments over 4 years is $18829.4, with a median of $16942.0 recorded in 2023.
• Year-over-year, Short-term Investments changed 0.0% in 2024 and soared 100.09% in 2025.
• Over 4 years, Short-term Investments stood at $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then soared by 100.09% to $33899.0 in 2025, then sank by 49.98% to $16957.0 in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $16957.0 in Q2 2026, $16957.0 in Q1 2026, and $33899.0 in Q4 2025.